NO990947D0 - Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon - Google Patents

Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon

Info

Publication number
NO990947D0
NO990947D0 NO990947A NO990947A NO990947D0 NO 990947 D0 NO990947 D0 NO 990947D0 NO 990947 A NO990947 A NO 990947A NO 990947 A NO990947 A NO 990947A NO 990947 D0 NO990947 D0 NO 990947D0
Authority
NO
Norway
Prior art keywords
pkc
medication
inhibitors
preparation
treatment
Prior art date
Application number
NO990947A
Other languages
English (en)
Other versions
NO990947L (no
Inventor
Michael R Jirousek
Douglas K Ways
Lawrence E Stramm
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1997/015583 external-priority patent/WO1998008510A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO990947D0 publication Critical patent/NO990947D0/no
Publication of NO990947L publication Critical patent/NO990947L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO990947A 1996-08-30 1999-02-26 Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon NO990947L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2486996P 1996-08-30 1996-08-30
US91736297A 1997-08-26 1997-08-26
PCT/US1997/015583 WO1998008510A1 (en) 1996-08-30 1997-08-28 Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection

Publications (2)

Publication Number Publication Date
NO990947D0 true NO990947D0 (no) 1999-02-26
NO990947L NO990947L (no) 1999-04-28

Family

ID=26698961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990947A NO990947L (no) 1996-08-30 1999-02-26 Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon

Country Status (11)

Country Link
EP (1) EP0834313A1 (no)
JP (1) JP2002514178A (no)
KR (1) KR20000035863A (no)
CN (1) CN1231607A (no)
BR (1) BR9711375A (no)
CA (1) CA2263499A1 (no)
EA (1) EA199900244A1 (no)
IL (1) IL128494A0 (no)
NO (1) NO990947L (no)
PL (1) PL331761A1 (no)
TR (1) TR199900774T2 (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506231A (en) * 1989-03-31 1996-04-09 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
WO1995000520A1 (en) * 1993-06-17 1995-01-05 Ciba-Geigy Ag Indolocarbazole compound useful as proteinkinase c inhibitor
BR9404831A (pt) * 1993-12-07 1995-08-08 Lilly Co Eli Composto,formulação farmacêutica e processo de preparação de um composto

Also Published As

Publication number Publication date
CA2263499A1 (en) 1998-03-05
EP0834313A1 (en) 1998-04-08
BR9711375A (pt) 1999-08-17
NO990947L (no) 1999-04-28
KR20000035863A (ko) 2000-06-26
JP2002514178A (ja) 2002-05-14
IL128494A0 (en) 2000-01-31
TR199900774T2 (xx) 1999-07-21
CN1231607A (zh) 1999-10-13
PL331761A1 (en) 1999-08-02
EA199900244A1 (ru) 1999-10-28

Similar Documents

Publication Publication Date Title
EE200200274A (et) Pürrolidiinatseetamiidi derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete ravimiseks, ja farmatseutiline kompositsioon
DE69622780T2 (de) Transdermales therapeutisches System mit kontrollierter Wirkstofffreisetzung
NO980146L (no) Epidural administrering av terapeutiske forbindelser med vedvarende frigjöringshastighet
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DE69203990T2 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DK1121114T3 (da) Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
DK0879054T3 (da) Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug
NO990947D0 (no) Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon
CY2388B1 (en) Rate-controlled transdermal administration of risperidone.
NO990450L (no) Behandling av sinnslidelser
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
FR2749586B1 (fr) Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
AU4250697A (en) Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
FI953622A (fi) Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon
IL156144A0 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
NO990948D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner
DK236489D0 (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
DE29501910U1 (de) Transdermales therapeutisches den Wirkstoff Dimethisoquin enthaltendes System
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application